Dharmesh Kharwar joins Entod Pharmaceuticals as independent director: Our Bureau, Mumbai Saturday, October 19, 2024, 11:30 Hrs [IST] Mumbai-based Entod Pharmaceuticals has appoint ...
MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...
Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...
EMA committee recommends marketing approval for Novartis’ Kisqali to help reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Saturday, October 19, 202 ...
Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines: Shardul Nautiyal, Mumbai Saturday, October ...
CARI advances studies on metabolic disorders via traditional and modern methodologies: Nandita Vijayasimha, Bengaluru Saturday, October 19, 2024, 08:00 Hrs [IST] The Central Ayurv ...
IPA opens permanent office at Kalina, new office-bearers take charge of the association: Peethaambaran Kunnathoor, Chennai Saturday, October 19, 2024, 08:00 Hrs [IST] The Indian P ...
Imports of bulk drugs and drug intermediates decline 13.2% in H1 FY25: Gireesh Babu, New Delhi Saturday, October 19, 2024, 08:00 Hrs [IST] The import of bulk drugs and drug interm ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), ...
Shaheen Majeed, global CEO & MD, Sami-Sabinsa Group elected as vice chairman, CII National Committee on IPR: Our Bureau, ...